AMP Peptide PL-5

PL-5 peptide · Jiangsu ProteLight Pharmaceutical & Biotechnology Co., Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for AMP Peptide PL-5, covering 2025-05-25 to 2025-05-25. Get the full timeline:

Most recent: Clinical Trial Update: Phase II Study to Evaluate Efficacy and Safety of AMP Peptide PL-5 in Mild Infections of Diabetic Foot Ulcers [Phase 2]

See pricing